Lung cancer remains the leading cause of cancer-related mortality across the globe, driving researchers to look closer at population-specific genetic vulnerabilities that might explain varying susceptibility.
In a recent publication in Nature, investigators explored whether specific genetic variations in the ataxia-telangiectasia mutated gene alter lung cancer risk within the Bangladeshi population.
The study focused on two single nucleotide polymorphisms within the ATM gene, which plays a central role in regulating how human cells respond to DNA damage. Researchers examined the rs189037 variant located in the 5’ untranslated region and the rs227091 variant situated in the 3’ untranslated region using a case-control design involving 250 total individuals, comparing lung cancer patients against healthy controls.
When evaluating the data under different inheritance models, the team found that the rs189037 AA genotype showed a nominal association with a higher risk of developing lung cancer, registering an odds ratio of 2.09 with a 95% confidence interval spanning from 1.22 to 3.53.
That elevated risk appeared even more pronounced among male participants in the cohort, where the odds ratio climbed to 2.19. By contrast, the rs227091 variant showed no statistically significant association with lung cancer risk under any of the genetic models tested by the research group.
Further analysis of genetic haplotypes revealed that the AT combination was potentially linked to an increased risk of the disease with an odds ratio of 1.445, while the GT combination appeared to confer a protective effect with an odds ratio of 0.297.
| Genetic Marker Model | Odds Ratio (OR) | 95% Confidence Interval | P-Value |
|---|---|---|---|
| rs189037 AA Genotype (Recessive) | 2.09 | 1.22–3.53 | 0.01 |
| rs189037 AA Genotype (Males) | 2.19 | Not Reported | 0.0097 |
| AT Haplotype Association | 1.445 | Not Reported | 0.046 |
| GT Haplotype Protection | 0.297 | Not Reported | < 0.0001 |
Computational and bioinformatic evaluations provided additional context for these genetic signals. Bioinformatic tools predicted that the rs227091 variant might alter multiple microRNA binding sites, whereas the rs189037 variant received a high RegulomeDB score indicating strong regulatory potential.
Yet, because these statistical findings remain uncorrected for multiple comparisons and stem from a modest sample size, independent research groups emphasize that the rs189037 AA genotype currently serves only as an exploratory candidate signal.
Larger, multicenter cohort studies will be necessary to confirm these genetic associations and thoroughly unpack the underlying molecular mechanisms driving them.